Dear Cashmere Holding Company (DRCR)
OTCMKTS · Delayed Price · Currency is USD
0.0331
+0.0002 (0.61%)
Aug 1, 2025, 3:55 PM EDT
Revance Therapeutics Market Cap
DRCR has a market cap or net worth of $1.78 million as of August 1, 2025. Its market cap has decreased by -85.42% in one year.
Market Cap
1.78M
Enterprise Value
n/a
Revenue
10.69M
Ranking
n/a
PE Ratio
0.17
Stock Price
$0.03
Market Cap Chart
Since January 26, 2011, DRCR's market cap has decreased from 2.50M to 1.78M, a decrease of -28.82%. That is a compound annual growth rate of -2.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.78M | -74.54% |
| Dec 31, 2024 | 6.99M | 106.03% |
| Dec 29, 2023 | 3.39M | -66.36% |
| Dec 30, 2022 | 10.08M | -83.74% |
| Dec 31, 2021 | 62.01M | 785.91% |
| Dec 16, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jingbo Technology | 2.84B |
| IPE Universal | 1.56B |
| AI Unlimited Group | 711.70M |
| Rand Worldwide | 503.10M |
| Applied Energetics | 468.44M |
| EACO Corporation | 316.00M |
| Motomova | 308.56M |
| Abaxx Technologies | 306.44M |